Literature DB >> 11118394

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.

C Manegold1, C Hannoun, A Wywiol, M Dietrich, S Polywka, C B Chiwakata, S Günther.   

Abstract

We describe 2 patients who were initially positive for antibodies to hepatitis B surface antigen and who experienced a strong and sudden increase of hepatitis B virus (HBV) replication during highly active antiretroviral therapy (HAART). We found that reactivation of HBV replication during HAART can occur independently of lamivudine resistance or withdrawal of lamivudine, and in spite of increasing CD4(+) cell counts.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11118394     DOI： 10.1086/317535

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  25 in total

Review 1.  The management of chronic hepatitis B in Asian Americans.

Authors:  Myron J Tong; Calvin Q Pan; Hie-Won Hann; Kris V Kowdley; Steven-Huy B Han; Albert D Min; Truong-Sinh Leduc
Journal:  Dig Dis Sci       Date:  2011-09-21       Impact factor: 3.199

Review 2.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  Long-Term 'Self-Managed' Immunosuppressive Treatment Resulting in Death due to Fulminant Hepatitis B : Medical Malpractice or Patient's Autolesionism?

Authors:  Roberto Manfredi; Sergio Sabbatani; Francesco Chiodo
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

5.  Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

Authors:  Kazuhiko Takeda; Mari Maruki; Takahiro Yamagaito; Machiko Muramatsu; Yasuhiro Sakai; Hiroaki Tobimatsu; Hironori Kobayashi; Yoshiteru Mizuno; Yukio Hamaguchi
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

Review 6.  Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV.

Authors:  Robert C Bollinger; Chloe L Thio; Mark S Sulkowski; Jane McKenzie-White; David L Thomas; Charles Flexner
Journal:  Lancet HIV       Date:  2019-12-20       Impact factor: 12.767

7.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

8.  Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.

Authors:  A J Chamorro; J L Casado; D Bellido; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

9.  Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination.

Authors:  Indhira De La Rosa; Iona M Munjal; Maria Rodriguez-Barradas; Xiaoying Yu; Liise-Anne Pirofski; Daniel Mendoza
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

Review 10.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.